547 related articles for article (PubMed ID: 9287957)
41. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
42. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice.
Remer KA; Apetrei C; Schwarz T; Linden C; Moll H
Eur J Immunol; 2007 Sep; 37(9):2463-73. PubMed ID: 17705130
[TBL] [Abstract][Full Text] [Related]
43. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
44. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
45. Early IL-4 production does not predict susceptibility to Leishmania major.
Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
[TBL] [Abstract][Full Text] [Related]
46. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
47. The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice.
Alavizadeh SH; Badiee A; Khamesipour A; Jalali SA; Firouzmand H; Abbasi A; Jaafari MR
Exp Parasitol; 2012 Nov; 132(3):313-9. PubMed ID: 22819791
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.
Gessner A; Will A; Vieth M; Schröppel K; Röllinghoff M
Immunology; 1995 Mar; 84(3):416-22. PubMed ID: 7751025
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.
Abdian N; Gholami E; Zahedifard F; Safaee N; Rafati S
Exp Parasitol; 2011 Mar; 127(3):627-36. PubMed ID: 21187087
[TBL] [Abstract][Full Text] [Related]
50. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
Ronet C; Hauyon-La Torre Y; Revaz-Breton M; Mastelic B; Tacchini-Cottier F; Louis J; Launois P
J Immunol; 2010 Jan; 184(2):886-94. PubMed ID: 19966209
[TBL] [Abstract][Full Text] [Related]
51. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.
Reinhard K; Huber M; Wostl C; Hellhund A; Toboldt A; Abass E; Casper B; Joeris T; Herr C; Bals R; Steinhoff U; Lohoff M; Visekruna A
Eur J Immunol; 2011 May; 41(5):1388-98. PubMed ID: 21469108
[TBL] [Abstract][Full Text] [Related]
52. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
53. Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major.
Daneshvar H; Burchmore R; Hagan P; Phillips RS
Parasitology; 2009 Sep; 136(11):1243-50. PubMed ID: 19646303
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
Gessner A; Blum H; Röllinghoff M
Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
[TBL] [Abstract][Full Text] [Related]
55. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
Wershil BK; Theodos CM; Galli SJ; Titus RG
J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
[TBL] [Abstract][Full Text] [Related]
56. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
57. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice.
Soudi S; Hosseini AZ; Hashemi SM
Parasite Immunol; 2011 Oct; 33(10):561-71. PubMed ID: 21781137
[TBL] [Abstract][Full Text] [Related]
58. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.
Yamakami K; Akao S; Sato M; Nitta Y; Miyazaki J; Tadakuma T
Parasitol Int; 2001 Jul; 50(2):81-91. PubMed ID: 11438430
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection.
Leal LM; Moss DW; Kuhn R; Müller W; Liew FY
Eur J Immunol; 1993 Feb; 23(2):566-9. PubMed ID: 8436188
[TBL] [Abstract][Full Text] [Related]
60. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
Nabors GS; Farrell JP
Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
